News >

Simon Says Immunotherapy Combo Regimens on Horizon in NSCLC

Danielle Bucco
Published: Monday, Dec 04, 2017

George R. Simon, MD

George R. Simon, MD
Immunotherapy continues to show single-agent efficacy in non–small cell lung cancer (NSCLC) and is now being investigated in combination regimens to further improve patient outcomes.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication